Lucid Diagnostics closes $15 million financing through Series C Preferred Stock private placement, bolstering its balance sheet. The funding supports near-term commercial acceleration following the start of Medicare reimbursement for EsoGuard.
Amount Raised
$15 Million
Round Type
Series C
Description
Lucid Diagnostics Inc. has begun receiving payments from Medicare for its EsoGuard® Esophageal DNA Test. The company closed a $15.0 million private placement for shares of its newly designated Series C Convertible Preferred Stock to existing long-term shareholders. This financing aims to strengthen Lucid's balance sheet and extend its cash runway
Quick answer
Lucid Diagnostics raised $15 Million in a Series C round, dated October 21, 2026. Lucid Diagnostics is based in New York, New York, United States.
- How much did Lucid Diagnostics raise?
- Lucid Diagnostics raised $15 Million in a Series C round on October 21, 2026.
- What does Lucid Diagnostics do?
- Lucid Diagnostics Inc. (Nasdaq: LUCD) is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM).
- Where is Lucid Diagnostics based and how big is it?
- Lucid Diagnostics is based in New York, New York, United States. Fundz records about 106 employees.
- Who are the decision-makers at Lucid Diagnostics?
- Fundz holds 5 contacts at Lucid Diagnostics, including the Senior Vice President of Sales. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Lucid Diagnostics that raised within 45 days of this round, from Fundz verified event records.
- VETmAb Biosciences raised an undisclosed amount on November 17, 2026.
- Science Corporation raised $400M (Series D) on November 17, 2026.
- Soombit AI raised $9M (Series A) on November 17, 2026.
- Qluster raised $5.2M (Pre-Seed) on November 17, 2026.
- AstraNu raised $3.5M (Seed) on November 17, 2026.
- Commit Biologics raised $60M (Seed) on November 17, 2026.
Who to call at Lucid Diagnostics, and when
A new round usually means Lucid Diagnostics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Lucid Diagnostics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lucid Diagnostics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lucid Diagnostics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lucid Diagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Lucid Diagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.